The interplay between inflammatory cytokines and cardiometabolic disease: bi-directional mendelian randomisation study

OBJECTIVE: To leverage large scale genetic association data to investigate the interplay between circulating cytokines and cardiometabolic traits, and thus identifying potential therapeutic targets. DESIGN: Bi-directional Mendelian randomisation study. SETTING: Genome-wide association studies from t...

Full description

Bibliographic Details
Published in:BMJ Medicine
Main Authors: Karhunen, Ville, Gill, Dipender, Huang, Jian, Bouras, Emmanouil, Malik, Rainer, Ponsford, Mark J, Ahola-Olli, Ari, Papadopoulou, Areti, Palaniswamy, Saranya, Sebert, Sylvain, Wielscher, Matthias, Auvinen, Juha, Veijola, Juha, Herzig, Karl-Heinz, Timonen, Markku, Keinänen-Kiukaanniemi, Sirkka, Dichgans, Martin, Salmi, Marko, Jalkanen, Sirpa, Lehtimäki, Terho, Salomaa, Veikko, Raitakari, Olli, Jones, Simon A, Hovingh, G Kees, Tsilidis, Konstantinos K, Järvelin, Marjo-Riitta, Dehghan, Abbas
Format: Text
Language:English
Published: BMJ Publishing Group 2023
Subjects:
Online Access:http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9978757/
https://doi.org/10.1136/bmjmed-2022-000157
id ftpubmed:oai:pubmedcentral.nih.gov:9978757
record_format openpolar
spelling ftpubmed:oai:pubmedcentral.nih.gov:9978757 2023-05-15T17:42:42+02:00 The interplay between inflammatory cytokines and cardiometabolic disease: bi-directional mendelian randomisation study Karhunen, Ville Gill, Dipender Huang, Jian Bouras, Emmanouil Malik, Rainer Ponsford, Mark J Ahola-Olli, Ari Papadopoulou, Areti Palaniswamy, Saranya Sebert, Sylvain Wielscher, Matthias Auvinen, Juha Veijola, Juha Herzig, Karl-Heinz Timonen, Markku Keinänen-Kiukaanniemi, Sirkka Dichgans, Martin Salmi, Marko Jalkanen, Sirpa Lehtimäki, Terho Salomaa, Veikko Raitakari, Olli Jones, Simon A Hovingh, G Kees Tsilidis, Konstantinos K Järvelin, Marjo-Riitta Dehghan, Abbas 2023-02-14 http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9978757/ https://doi.org/10.1136/bmjmed-2022-000157 en eng BMJ Publishing Group http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9978757/ http://dx.doi.org/10.1136/bmjmed-2022-000157 © Author(s) (or their employer(s)) 2023. Re-use permitted under CC BY. Published by BMJ. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution 4.0 Unported (CC BY 4.0) license, which permits others to copy, redistribute, remix, transform and build upon this work for any purpose, provided the original work is properly cited, a link to the licence is given, and indication of whether changes were made. See: https://creativecommons.org/licenses/by/4.0/. BMJ Med Research Text 2023 ftpubmed https://doi.org/10.1136/bmjmed-2022-000157 2023-03-19T01:37:57Z OBJECTIVE: To leverage large scale genetic association data to investigate the interplay between circulating cytokines and cardiometabolic traits, and thus identifying potential therapeutic targets. DESIGN: Bi-directional Mendelian randomisation study. SETTING: Genome-wide association studies from three Finnish cohorts (Northern Finland Birth Cohort 1966, Young Finns Study, or FINRISK study), and genetic association summary statistics pooled from observational studies for expression quantitative trait loci and cardiometabolic traits. PARTICIPANTS: Data for 47 circulating cytokines in 13 365 individuals from genome-wide association studies, summary statistic data for up to 21 735 individuals on circulating cytokines, summary statistic gene expression data across 49 tissues in 838 individuals, and summary statistic data for up to 1 320 016 individuals on cardiometabolic traits. INTERVENTIONS: Relations between circulating cytokines and cardiovascular, anthropometric, lipid, or glycaemic traits (coronary artery disease, stroke, type 2 diabetes mellitus, body mass index, waist circumference, waist to hip ratio, systolic blood pressure, glycated haemoglobin, high density lipoprotein cholesterol, low density lipoprotein cholesterol, total cholesterol, triglycerides, C reactive protein, glucose, fasting insulin, and lifetime smoking). MAIN OUTCOME METHODS: Genetic instrumental variables that are biologically plausible for the circulating cytokines were generated. The effects of cardiometabolic risk factors on concentrations of circulating cytokines, circulating cytokines on other circulating cytokines, and circulating cytokines on cardiometabolic outcomes were investigated. RESULTS: Genetic evidence (mendelian randomisation P<0.0011) suggests that higher body mass index, waist circumference, smoking, higher concentrations of lipids, and systolic blood pressure increase circulating concentrations of several inflammatory cytokines and C reactive protein. Evidence for causal relations (mendelian randomisation ... Text Northern Finland PubMed Central (PMC) BMJ Medicine 2 1 e000157
institution Open Polar
collection PubMed Central (PMC)
op_collection_id ftpubmed
language English
topic Research
spellingShingle Research
Karhunen, Ville
Gill, Dipender
Huang, Jian
Bouras, Emmanouil
Malik, Rainer
Ponsford, Mark J
Ahola-Olli, Ari
Papadopoulou, Areti
Palaniswamy, Saranya
Sebert, Sylvain
Wielscher, Matthias
Auvinen, Juha
Veijola, Juha
Herzig, Karl-Heinz
Timonen, Markku
Keinänen-Kiukaanniemi, Sirkka
Dichgans, Martin
Salmi, Marko
Jalkanen, Sirpa
Lehtimäki, Terho
Salomaa, Veikko
Raitakari, Olli
Jones, Simon A
Hovingh, G Kees
Tsilidis, Konstantinos K
Järvelin, Marjo-Riitta
Dehghan, Abbas
The interplay between inflammatory cytokines and cardiometabolic disease: bi-directional mendelian randomisation study
topic_facet Research
description OBJECTIVE: To leverage large scale genetic association data to investigate the interplay between circulating cytokines and cardiometabolic traits, and thus identifying potential therapeutic targets. DESIGN: Bi-directional Mendelian randomisation study. SETTING: Genome-wide association studies from three Finnish cohorts (Northern Finland Birth Cohort 1966, Young Finns Study, or FINRISK study), and genetic association summary statistics pooled from observational studies for expression quantitative trait loci and cardiometabolic traits. PARTICIPANTS: Data for 47 circulating cytokines in 13 365 individuals from genome-wide association studies, summary statistic data for up to 21 735 individuals on circulating cytokines, summary statistic gene expression data across 49 tissues in 838 individuals, and summary statistic data for up to 1 320 016 individuals on cardiometabolic traits. INTERVENTIONS: Relations between circulating cytokines and cardiovascular, anthropometric, lipid, or glycaemic traits (coronary artery disease, stroke, type 2 diabetes mellitus, body mass index, waist circumference, waist to hip ratio, systolic blood pressure, glycated haemoglobin, high density lipoprotein cholesterol, low density lipoprotein cholesterol, total cholesterol, triglycerides, C reactive protein, glucose, fasting insulin, and lifetime smoking). MAIN OUTCOME METHODS: Genetic instrumental variables that are biologically plausible for the circulating cytokines were generated. The effects of cardiometabolic risk factors on concentrations of circulating cytokines, circulating cytokines on other circulating cytokines, and circulating cytokines on cardiometabolic outcomes were investigated. RESULTS: Genetic evidence (mendelian randomisation P<0.0011) suggests that higher body mass index, waist circumference, smoking, higher concentrations of lipids, and systolic blood pressure increase circulating concentrations of several inflammatory cytokines and C reactive protein. Evidence for causal relations (mendelian randomisation ...
format Text
author Karhunen, Ville
Gill, Dipender
Huang, Jian
Bouras, Emmanouil
Malik, Rainer
Ponsford, Mark J
Ahola-Olli, Ari
Papadopoulou, Areti
Palaniswamy, Saranya
Sebert, Sylvain
Wielscher, Matthias
Auvinen, Juha
Veijola, Juha
Herzig, Karl-Heinz
Timonen, Markku
Keinänen-Kiukaanniemi, Sirkka
Dichgans, Martin
Salmi, Marko
Jalkanen, Sirpa
Lehtimäki, Terho
Salomaa, Veikko
Raitakari, Olli
Jones, Simon A
Hovingh, G Kees
Tsilidis, Konstantinos K
Järvelin, Marjo-Riitta
Dehghan, Abbas
author_facet Karhunen, Ville
Gill, Dipender
Huang, Jian
Bouras, Emmanouil
Malik, Rainer
Ponsford, Mark J
Ahola-Olli, Ari
Papadopoulou, Areti
Palaniswamy, Saranya
Sebert, Sylvain
Wielscher, Matthias
Auvinen, Juha
Veijola, Juha
Herzig, Karl-Heinz
Timonen, Markku
Keinänen-Kiukaanniemi, Sirkka
Dichgans, Martin
Salmi, Marko
Jalkanen, Sirpa
Lehtimäki, Terho
Salomaa, Veikko
Raitakari, Olli
Jones, Simon A
Hovingh, G Kees
Tsilidis, Konstantinos K
Järvelin, Marjo-Riitta
Dehghan, Abbas
author_sort Karhunen, Ville
title The interplay between inflammatory cytokines and cardiometabolic disease: bi-directional mendelian randomisation study
title_short The interplay between inflammatory cytokines and cardiometabolic disease: bi-directional mendelian randomisation study
title_full The interplay between inflammatory cytokines and cardiometabolic disease: bi-directional mendelian randomisation study
title_fullStr The interplay between inflammatory cytokines and cardiometabolic disease: bi-directional mendelian randomisation study
title_full_unstemmed The interplay between inflammatory cytokines and cardiometabolic disease: bi-directional mendelian randomisation study
title_sort interplay between inflammatory cytokines and cardiometabolic disease: bi-directional mendelian randomisation study
publisher BMJ Publishing Group
publishDate 2023
url http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9978757/
https://doi.org/10.1136/bmjmed-2022-000157
genre Northern Finland
genre_facet Northern Finland
op_source BMJ Med
op_relation http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9978757/
http://dx.doi.org/10.1136/bmjmed-2022-000157
op_rights © Author(s) (or their employer(s)) 2023. Re-use permitted under CC BY. Published by BMJ.
https://creativecommons.org/licenses/by/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution 4.0 Unported (CC BY 4.0) license, which permits others to copy, redistribute, remix, transform and build upon this work for any purpose, provided the original work is properly cited, a link to the licence is given, and indication of whether changes were made. See: https://creativecommons.org/licenses/by/4.0/.
op_doi https://doi.org/10.1136/bmjmed-2022-000157
container_title BMJ Medicine
container_volume 2
container_issue 1
container_start_page e000157
_version_ 1766144613409619968